Press Releases

Date	Title	Company
25-Jul-2023	Bryn Pharma Announces Expansion of Leadership Team as UTULY™ Investigative Needle-Free Epinephrine Nasal Spray Prepares for Market Entry	Businesswire
25-Jul-2023	Smart Pill Boxes & Bottles: Paving the Path to a US$ 388.2 Million Revolution in Medication Management by the end of 2033 \| FMI Study	MARKITWIRED
25-Jul-2023	Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market to Reach $4.02 Billion by the End of 2030	The Wire Times
25-Jul-2023	State of Specialty Spend and Trend Report Released by Pharmaceutical Strategies Group	Businesswire
25-Jul-2023	Blue Earth Diagnostics Announces Addition of POSLUMA® (Flotufolastat F 18) Injection to NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Prostate Cancer	Businesswire
25-Jul-2023	Rising Above the Norm: Branded Generics Market Surges to a Remarkable US$ 327.8 Million at a Thriving CAGR of 8.6% \| FMI	MARKITWIRED
25-Jul-2023	An Introduction to ISO 22716: Cosmetic Products GMP (Good Manufacturing Practice) Training Course - Enhance Your Cosmetic Production Process - ResearchAndMarkets.com	Businesswire
25-Jul-2023	Fore Genomics Adopts DNAnexus Platform to Access and Analyze Whole-Genome Newborn Screening Data	Businesswire
25-Jul-2023	Rhinostics Launches the ELEstic™/ELEbot™ Platform, Bringing Proven Automated Swab Workflows to Broad Diagnostics Systems	Businesswire
25-Jul-2023	Cureline Group’s Full Range of Research Services Now Available Through Scientist.com	Businesswire
25-Jul-2023	Respiratory Devices Global Market - Forecast to 2029 - ResearchAndMarkets.com	Businesswire
25-Jul-2023	Evidence from Electronic Health Records-to-Electronic Data Capture live pilot study	IgniteData
25-Jul-2023	SQZ Biotechnologies Provides Update on Collaboration with Roche	Businesswire
25-Jul-2023	Electrophysiology Market Size Expected to Reach USD 12.87 Billion with Growing CAGR of 8.30% by 2029	The Wire Times
25-Jul-2023	Empty Capsules Market to Notice Exponential CAGR Growth of 8.4% Forecast by 2029	The Wire Times
25-Jul-2023	Astellas and PeptiDream Enter into Research Collaboration and License Agreement to Discover Novel Targeted Protein Degraders	Businesswire
25-Jul-2023	Stoke Therapeutics Announces Positive New Safety & Efficacy Data from Patients Treated with STK-001 in the Phase 1/2a Studies (MONARCH & ADMIRAL) and the SWALLOWTAIL Open-Label Extension (OLE) Study in Children and Adolescents with Dravet Syndrome	Businesswire
25-Jul-2023	KalVista Pharmaceuticals Expands Senior Leadership Team with Appointment of Nicole Sweeny as Chief Commercial Officer	Businesswire
25-Jul-2023	GE HealthCare Reports Second Quarter 2023 Financial Results	Businesswire
25-Jul-2023	Jardiance® (empagliflozin) approved in the EU for the treatment of adults with chronic kidney disease	Boehringer Ingelheim